Form D · Biotechnology

RLL, LLC

Lutherville, MD · CIK 0001755433

Offering snapshot reported Apr 6, 2026 · SEC filing

Reported sold
$1.98M
Indefinite offering
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 6, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 6, 2026Initial$1,984,621No comparison11SEC filing
Jun 24, 2025InitialYet to sellNo comparison0SEC filing
Dec 2, 2024InitialYet to sellNo comparison0SEC filing
Jul 27, 2021Initial$8,015,002No comparisonNot reportedSEC filing
Feb 26, 2020Initial$1,537,316No comparison2SEC filing
Apr 5, 2019Initial$500,000No comparison1SEC filing
Oct 9, 2018Initial$684,211No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-579191
The securities are simple agreements for future equity (SAFEs) that also accrues interest with a valuation cap

Source: Form D, filed Apr 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Brinkenhoff Director
Robert Hickey Director
Linda Malkas Director
Lauren Schnaper Director, Executive, Promoter
Jonathan Thomas Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11801 Berans Road
Lutherville, MD, 21093